Funder
The State Key Program of National Natural Science of China
Project of National Science Foundation of China
The innovation program of science and research from DICP, CAS
Innovation platform for the development and construction of special project of Key Laboratory of Tibetan Medicine Research of Qinghai Province
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference48 articles.
1. Aramori I, Nirei H, Shoubo M, Sogabe K, Nakamura K, Kojo H, Notsu Y, Ono T, Nakanishi S (1993) Subtype selectivity of a novel endothelin antagonist, FR139317, for the 2 endothelin receptors in transfected Chinese-hamster ovary cells. Mol Pharmacol 43(2):127–131
2. Christensen HB, Gloriam DE, Pedersen DS, Cowland JB, Borregaard N, Brauner-Osborne H (2017) Applying label-free dynamic mass redistribution assay for studying endogenous FPR1 receptor signalling in human neutrophils. J Pharmacol Toxicol Methods 88(Pt 1):72–78. https://doi.org/10.1016/j.vascn.2017.07.003
3. Clozel M, Breu V, Gray GA, Kalina B, Loffler BM, Burri K, Cassal JM, Hirth G, Muller M, Neidhart W, Ramuz H (1994) Pharmacological characterization of Bosentan, a new potent orally-active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 270(1):228–235
4. Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, Pollock DM, Webb DJ, Maguire JJ (2016) Endothelin. Pharmacol Rev 68(2):357–418. https://doi.org/10.1124/pr.115.011833
5. Deng H, Fang Y (2013) The three catecholics benserazide, catechol and pyrogallol are GPR35 agonists. Pharmaceuticals (Basel, Switzerland) 6(4):500–509. https://doi.org/10.3390/ph6040500
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献